Detection of immunogenic cell death and its relevance for cancer therapy J Fucikova, O Kepp, L Kasikova, G Petroni, T Yamazaki, P Liu, L Zhao, ... Cell death & disease 11 (11), 1013, 2020 | 551 | 2020 |
Crizotinib-induced immunogenic cell death in non-small cell lung cancer P Liu, L Zhao, J Pol, S Levesque, A Petrazzuolo, C Pfirschke, C Engblom, ... Nature communications 10 (1), 1486, 2019 | 236 | 2019 |
eIF2α phosphorylation is pathognomonic for immunogenic cell death L Bezu, A Sauvat, J Humeau, LC Gomes-da-Silva, K Iribarren, S Forveille, ... Cell Death & Differentiation 25 (8), 1375-1393, 2018 | 204 | 2018 |
Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade G Ferrere, MT Alou, P Liu, AG Goubet, M Fidelle, O Kepp, S Durand, ... JCI insight 6 (2), 2021 | 177 | 2021 |
Photodynamic therapy with redaporfin targets the endoplasmic reticulum and Golgi apparatus LC Gomes‐da‐Silva, L Zhao, L Bezu, H Zhou, A Sauvat, P Liu, S Durand, ... The EMBO journal 37 (13), e98354, 2018 | 108 | 2018 |
Immunosuppression by mutated calreticulin released from malignant cells P Liu, L Zhao, F Loos, C Marty, W Xie, I Martins, S Lachkar, BO Qu, ... Molecular cell 77 (4), 748-760. e9, 2020 | 97 | 2020 |
IGF1 receptor inhibition amplifies the effects of cancer drugs by autophagy and immune-dependent mechanisms Q Wu, AL Tian, B Li, M Leduc, S Forveille, P Hamley, W Galloway, W Xie, ... Journal for immunotherapy of cancer 9 (6), 2021 | 47 | 2021 |
A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers M Fidelle, C Rauber, C Alves Costa Silva, AL Tian, I Lahmar, ... Science 380 (6649), eabo2296, 2023 | 46 | 2023 |
Identification of pharmacological agents that induce HMGB1 release P Liu, L Zhao, F Loos, K Iribarren, S Lachkar, H Zhou, LC Gomes-da-Silva, ... Scientific reports 7 (1), 14915, 2017 | 46 | 2017 |
A TLR3 ligand reestablishes chemotherapeutic responses in the context of FPR1 deficiency J Le Naour, P Liu, L Zhao, S Adjemian, Z Sztupinszki, J Taieb, C Mulot, ... Cancer Discovery 11 (2), 408-423, 2021 | 36 | 2021 |
Crizotinib–a tyrosine kinase inhibitor that stimulates immunogenic cell death P Liu, L Zhao, O Kepp, G Kroemer Oncoimmunology 8 (7), e1596652, 2019 | 35 | 2019 |
PD-1 blockade synergizes with oxaliplatin-based, but not cisplatin-based, chemotherapy of gastric cancer P Liu, J Chen, L Zhao, A Hollebecque, O Kepp, L Zitvogel, G Kroemer Oncoimmunology 11 (1), 2093518, 2022 | 33 | 2022 |
The oncolytic compound LTX-401 targets the Golgi apparatus H Zhou, A Sauvat, LC Gomes-da-Silva, S Durand, S Forveille, K Iribarren, ... Cell Death & Differentiation 23 (12), 2031-2041, 2016 | 29 | 2016 |
Lysosomotropic agents including azithromycin, chloroquine and hydroxychloroquine activate the integrated stress response AL Tian, Q Wu, P Liu, L Zhao, I Martins, O Kepp, M Leduc, G Kroemer Cell Death & Disease 12 (1), 6, 2021 | 27 | 2021 |
Identification of pharmacological inhibitors of conventional protein secretion L Zhao, P Liu, G Boncompain, F Loos, S Lachkar, L Bezu, G Chen, ... Scientific reports 8 (1), 1-11, 2018 | 22 | 2018 |
Quantitation of calreticulin exposure associated with immunogenic cell death P Liu, L Zhao, O Kepp, G Kroemer Methods in Enzymology 632, 1-13, 2020 | 21 | 2020 |
Oncolysis with DTT-205 and DTT-304 generates immunological memory in cured animals H Zhou, L Mondragón, W Xie, B Mauseth, M Leduc, A Sauvat, ... Cell Death & Disease 9 (11), 1086, 2018 | 21 | 2018 |
Redaporfin induces immunogenic cell death by selective destruction of the endoplasmic reticulum and the Golgi apparatus LC Gomes-da-Silva, L Zhao, LG Arnaut, G Kroemer, O Kepp Oncotarget 9 (58), 31169, 2018 | 20 | 2018 |
Surface-exposed and soluble calreticulin: conflicting biomarkers for cancer prognosis O Kepp, P Liu, L Zhao, I Plo, G Kroemer Oncoimmunology 9 (1), 1792037, 2020 | 18 | 2020 |
Isobacachalcone induces autophagy and improves the outcome of immunogenic chemotherapy Q Wu, AL Tian, S Durand, F Aprahamian, N Nirmalathasan, W Xie, P Liu, ... Cell Death & Disease 11 (11), 1015, 2020 | 17 | 2020 |